ESTRO Guide 2018

First page Table of contents Previous page 128 Next page Last page

Scientific Programme

TEACHING LECTURE

Radiation-induced cardiac toxicity: what have we learnt?

Measuring the systemic immune- modulated effect of radiation

Optimal sequence in the treatment of breast cancer: radiotherapy first?

Standard of care in the treatment of bladder cancer

08:00 - 08:40

SYMPOSIUM

Partial organ treatments to minimise late radiation effects Evidence for partial organ treatments - Variation in dose distribution by different radiation modalities - Imaging and treatment planning for partial organ treatments - Patient choice for partial organ treatment and survivorship issues

Radiotherapy combined with immuno- therapy: mechanisms and biomarkers Mechanisms predicting the benefit of adding immune checkpoint inhibitors together with radiotherapy - Systemic effects of radiotherapy: immune mechanisms, pre-clinical data and clinical evidence - Importance of immunogenic cell death when adding immunotherapy together with radiotherapy - Immunocytokines: the ideal immunotherapy to combine with radiotherapy?

More of both? Breast reconstruction and regional lymph node irradiation Breast reconstruction: a past or present challenge for the radiation oncologist? - Who might benefit most from regional nodal irradiation? A practical guide based on the EBCTCG meta-analysis - Brother and sister: guidelines for bringing breast reconstruction and radiation therapy together

Current issues in the treatment of muscle-invasive bladder cancer Organ preservation in bladder cancer – an evidence-based alternative to radical surgery - Is there a role for pelvic radiotherapy in muscle- invasive bladder cancer? - When should we give radiotherapy following cystectomy and how?

08:45 - 10:00

SATURDAY 21 APRIL 2018

COFFEE BREAK

10:00 - 10:30

SYMPOSIUM

PROFFERED PAPERS

Improving radiation therapy in breast cancer by avoiding side effects Cost-effective implementation of respiratory control for all - Getting the best out of the machines: techniques to avoid side effects - Between high-tech and biology: how to exploit protons, minibeams and flash irradiation to avoid toxicity? - Second cancers after radiotherapy for breast cancer

10:30 – 11:45

12:00 - 12:30

PRESIDENTIAL SYMPOSIUM

12:30 - 13.00

EMMANUEL VAN DER SCHUEREN AWARD LECTURE

13:00 - 14:30

LUNCH AND INDUSTRY SYMPOSIA

SYMPOSIUM

JOINT SYMPOSIUM

ESTRO- ASTRO

ESTRO- ESGO State of the art: new ESGO-ESTRO-ESP guidelines on management of cervical cancer

Lung and dose escalation Why RTOG 0617 failed and what lessons to be learned for the future? - Combining systemic therapy with hypofractionation in locally advanced NSCLC: best of both worlds or double-trouble? - Model-based approach to select the optimal technology for LA-NSCLC

Blood borne biomarkers Circulating tumour DNA - Microvesicles / hypoxia - Mitochondrial study

14:30 - 15:45

15:45 - 16:15

COFFEE BREAK

SYMPOSIUM

PROFFERED PAPERS

How to minimise toxicity in pelvic malig- nancies in the era of precision radiotherapy Hematologic toxicity during radiotherapy for pelvic malignancies: how to reduce it? - High precision prostate radiotherapy: a bigger bang for your buck - Preserving bladder function with brachytherapy for muscle-invasive bladder carcinoma - Determinants of toxicity in pelvic radiotherapy

16:15 - 17:30

CONFERENCES

17:45 - 18:30

HONORARY MEMBERS AWARD LECTURES

18:40 - 19:40

POSTER AWARDS CEREMONY

128

Made with FlippingBook Online newsletter